Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Issue 3 (September 2015)

• Record Type: Journal Article
• Authors: Kadota, Kyuichi; Buitrago, Daniel; Lee, Ming-Ching; Villena-Vargas, Jonathan; Sima, Camelia S.; Jones, David R.; Travis, William D.; Adusumilli, Prasad S.
• Is Part Of: Lung cancer. Volume 89:Issue 3(2015:Sep.)
• Page Start: 329
• Page End: 336
• Publication Date: 2015-09
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/j.lungcan.2015.06.003
• Languages: English
• ISSNs: 0169-5002

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Tumoral CD10 correlates with high-grade tumor histology.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Tumoral CD10 is a predictor of recurrence in intermediate-grade tumors.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">CD10 stratifies patients with intermediate-grade tumors into two prognostic subgroups.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">CD10 helps select patients at high-risk of recurrence for post-surgery adjuvant therapy.</p> </list-item> </list> </p> </sec> </abstract>